{"schema_version":"1","generated_at":"2026-11-13T18:12:34.288Z","data_as_of":"2026-11-13","url":"https://www.findmykol.com/kol/carlos-ramos","json_url":"https://www.findmykol.com/kol/carlos-ramos/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"carlos-ramos","name":"Carlos Ramos","credential":"MD","title":"Hematologist","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Lymphoma","therapeutic_areas":["Lymphoma","Leukemia","Sarcoma","Oncology"],"institution":"Baylor College of Medicine","institution_url":"https://www.findmykol.com/institution/baylor-college-of-medicine","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1619162906"},"summary":"Carlos Ramos is Hematologist at Baylor College of Medicine. ClinicalTrials.gov lists 17 registered studies with this person as an investigator.","overview":{"text":"Carlos Ramos, MD, is Hematologist at Baylor College of Medicine. It also documents an investigator role on 17 registered clinical trials, industry payments reported by 9 companies, 2 NIH-funded awards (2010–2026).","bullets":["Top research focus: Lymphoma","17 registered trials on ClinicalTrials.gov","Open Payments reporting from 9 companies"],"generated_at":"2026-11-13"},"focus":{"indications":[{"label":"Lymphoma","therapeutic_area":"Oncology","trials":10,"topics":0,"strength":30},{"label":"Hodgkin Disease","therapeutic_area":"Oncology","trials":7,"topics":0,"strength":21},{"label":"Lymphoma, Non-Hodgkin","therapeutic_area":"Oncology","trials":5,"topics":0,"strength":15},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":4,"topics":0,"strength":12},{"label":"Leukemia, Lymphocytic, Chronic, B-Cell","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Coma","therapeutic_area":"Neurology","trials":2,"topics":0,"strength":6},{"label":"Fatty Liver","therapeutic_area":"Gastroenterology","trials":2,"topics":0,"strength":6},{"label":"Fatty Liver, Alcoholic","therapeutic_area":"Gastroenterology","trials":2,"topics":0,"strength":6},{"label":"Leukemia, Lymphoid","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Non-alcoholic Fatty Liver Disease","therapeutic_area":"Gastroenterology","trials":2,"topics":0,"strength":6},{"label":"Recurrence","therapeutic_area":"Epidemiology","trials":2,"topics":0,"strength":6},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Diabetic Neuropathies","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Hepatitis C","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"Hepatitis C, Chronic","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"Hepatitis, Chronic","therapeutic_area":"Gastroenterology","trials":1,"topics":0,"strength":3},{"label":"Leiomyosarcoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Leukemia, B-Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma, B-Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma, T-Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Myosarcoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Nasopharyngeal Carcinoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Papilloma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Viral Hepatitis (B/C)","therapeutic_area":"Gastroenterology","trials":1,"topics":0,"strength":3}],"research_topics":["Lymphoma","Hodgkin Disease","Leukemia (AML/ALL/CML/CLL)","Leukemia, Lymphocytic, Chronic, B-Cell","Lymphoma, Non-Hodgkin","Leukemia, Lymphoid","Leiomyosarcoma","Leukemia, B-Cell","Lymphoma, B-Cell","Lymphoma, T-Cell","Myosarcoma","Nasopharyngeal Carcinoma","Papilloma","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Sarcoma"],"drugs_studied":{"total":6,"shown":3,"withheld":3,"rows":[{"name":"Darzalex","generic":"Daratumumab","trials":0,"payments":3,"publications":0,"mentions":3},{"name":"Imbruvica","generic":"Ibrutinib","trials":0,"payments":2,"publications":0,"mentions":2},{"name":"Kymriah","generic":"Tisagenlecleucel","trials":0,"payments":2,"publications":0,"mentions":2}]},"works_with":{"total":15,"shown":3,"withheld":12,"rows":[{"name":"Baylor College of Medicine","trials":8,"payments":0,"mentions":8},{"name":"Janssen Biotech, Inc.","trials":0,"payments":3,"mentions":3},{"name":"GlaxoSmithKline","trials":2,"payments":0,"mentions":2}]}},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":17,"shown":3,"withheld":14,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07221227","title":"A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH","phase":"PHASE3","status":"RECRUITING","role":"Investigator","sponsor":"GlaxoSmithKline","source_url":"https://clinicaltrials.gov/study/NCT07221227","trial_url":"https://www.findmykol.com/trial/NCT07221227"},{"nct":"NCT07221188","title":"A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH","phase":"PHASE3","status":"RECRUITING","role":"Investigator","sponsor":"GlaxoSmithKline","source_url":"https://clinicaltrials.gov/study/NCT07221188","trial_url":"https://www.findmykol.com/trial/NCT07221188"},{"nct":"NCT05487651","title":"Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies","phase":"PHASE1","status":"UNKNOWN","role":"Investigator","sponsor":"Athenex, Inc.","source_url":"https://clinicaltrials.gov/study/NCT05487651","trial_url":"https://www.findmykol.com/trial/NCT05487651"}],"source":"trials"},"payments":{"company_count":9,"program_years":{"first":2021,"last":2025},"rows_total":9,"shown":3,"withheld":6,"rows":[{"payer":"Kite Pharma, Inc.","program_year":2025,"amount_usd":30.29,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1619162906"},{"payer":"Celgene Corporation","program_year":2025,"amount_usd":24.89,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1619162906"},{"payer":"NOVARTIS PHARMACEUTICALS CORPORATION","program_year":2023,"amount_usd":139.5,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1619162906"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1619162906","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Anti-infectives","share_pct":34.9,"classes_total":2,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":24.5,"drugs":[{"name":"Valacyclovir","share_pct":100}],"max_beneficiaries":null},{"class":"Azole Antifungal","setting":"prescribed","share_pct":10.4,"drugs":[{"name":"Fluconazole","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":33,"classes_total":2,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":22.6,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":null},{"class":"SNRI","setting":"prescribed","share_pct":10.4,"drugs":[{"name":"Duloxetine Hcl","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":20.8,"classes_total":2,"classes":[{"class":"Bile Acid","setting":"prescribed","share_pct":10.4,"drugs":[{"name":"Ursodiol","share_pct":100}],"max_beneficiaries":null},{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":10.4,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":2,"fiscal_years":{"first":2010,"last":2026},"rows_total":48,"shown":3,"withheld":45,"rows":[{"project":"S10GM164872","title":"Acquisition of a Seahorse XF Pro Analyzer for Biomedical Research and Education in Metabolic Profiling","fiscal_year":2026,"amount_usd":249961,"organization":"UNIVERSITY OF PUERTO RICO MED SCIENCES","source_url":"https://reporter.nih.gov/quickSearch/S10GM164872"},{"project":"P30CA125123","title":"Protocol Review and Monitoring System","fiscal_year":2026,"amount_usd":65489,"organization":"BAYLOR COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/P30CA125123"},{"project":"R01CA298804","title":"Nanotechnology enabled quantitative imaging of dendritic cell anti-cancer vaccines","fiscal_year":2025,"amount_usd":2628974,"organization":"UNIVERSITY OF FLORIDA","source_url":"https://reporter.nih.gov/quickSearch/R01CA298804"}],"source":"grants"},"publications":{"total":0,"shown":0,"withheld":0,"recent":[],"source":"works"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"MD","source_url":"https://www.healthgrades.com/physician/dr-carlos-ramos-xxndq","status":"provisional","collected_at":"2026-11-13"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Houston Methodist Hospital","source_url":"https://blogs.bcm.edu/2024/06/04/following-up-with-long-term-survivor-of-car-t-cell-therapy/","status":"provisional","collected_at":"2026-11-13"}]},"media":{"total":3,"shown":3,"rows":[{"value":"SOHO 2022 video: CAR T-Cell Therapy in Hodgkin Lymphoma","source_url":"https://www.vumedi.com/video/soho-2022-car-t-cell-therapy-in-hodgkin-lymphoma/","status":"provisional","collected_at":"2026-11-13"},{"value":"ASH 2018 talk video: CD30 CAR-T therapy for HL","source_url":"https://www.youtube.com/watch?v=T7CsIAo5wfU","status":"provisional","collected_at":"2026-11-13"},{"value":"EBMT 2018 talk video (Baylor College of Medicine, Houston)","source_url":"https://www.youtube.com/watch?v=3k2XSzcHoEs","status":"provisional","collected_at":"2026-11-13"}]}},"similar":[{"name":"Christie Ballantyne","slug":"christie-ballantyne","institution":"Baylor College of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/christie-ballantyne","json_url":"https://www.findmykol.com/kol/christie-ballantyne/profile.json"},{"name":"Joseph Jankovic","slug":"joseph-jankovic","institution":"Baylor College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/joseph-jankovic","json_url":"https://www.findmykol.com/kol/joseph-jankovic/profile.json"},{"name":"Hashem El-Serag","slug":"hashem-el-serag","institution":"Baylor College of Medicine","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/hashem-el-serag","json_url":"https://www.findmykol.com/kol/hashem-el-serag/profile.json"},{"name":"Biykem Bozkurt","slug":"biykem-bozkurt","institution":"Baylor College of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/biykem-bozkurt","json_url":"https://www.findmykol.com/kol/biykem-bozkurt/profile.json"},{"name":"Seth Steinberg","slug":"seth-steinberg","institution":"National Cancer Institute (NCI)","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/seth-steinberg","json_url":"https://www.findmykol.com/kol/seth-steinberg/profile.json"},{"name":"Gilles Salles","slug":"gilles-salles","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/gilles-salles","json_url":"https://www.findmykol.com/kol/gilles-salles/profile.json"},{"name":"Julie Vose","slug":"julie-vose","institution":"University of Nebraska Medical Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/julie-vose","json_url":"https://www.findmykol.com/kol/julie-vose/profile.json"},{"name":"Bruce Cheson","slug":"bruce-cheson","institution":"The Center for Cancer and Blood Disorders","specialty":"Hematology","url":"https://www.findmykol.com/kol/bruce-cheson","json_url":"https://www.findmykol.com/kol/bruce-cheson/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":14,"payments":6,"funding":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-13"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-11-13"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-11-13"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}